Sponsor:
Jacobio Pharmaceuticals Co., Ltd.
Code:
NCT04720976
Conditions
Solid Tumor
NSCLC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
JAB-3312
Binimetinib
Pembrolizumab
Sotorasib
Osimertinib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations